Skip to Main Content

Paper Details

Identification and Characterization of IMD-0354 as a Glutamine Carrier Protein Inhibitor in Melanoma.
Mol Cancer Ther
13
2021
ASCT2, GLS1, Glutamine, Glutamine Carrier Protein, IMD-0354, LDHA, Melanoma, RNA, SLC1A5, breast cancer, cancer, cancers, glutamine, glutamine transporters, mTOR, melanoma, melanoma cell, melanoma cells, nontransformed cells, patients, tumor, tumor-derived cell lines, tumors, xenograft
Author NameAffiliation
Yongmei FengCancer Center, Sanford Burnham Prebys Medical Discovery Institute
Susanne Heynen-GenelCancer Center, Sanford Burnham Prebys Medical Discovery Institute
Brian JamesCancer Center, Sanford Burnham Prebys Medical Discovery Institute
David A ScottCancer Center, Sanford Burnham Prebys Medical Discovery Institute
Ze'ev RonaiCancer Center, Sanford Burnham Prebys Medical Discovery Institute
Ze'ev RonaiCancer Center, Sanford Burnham Prebys Medical Discovery Institute
  • 1 - 6

Datasets

Release 1.2